High-performance liquid chromatographic assay of anti-inflammatory drugs incorporated in gel ointments Separation and stability testing

https://doi.org/10.1016/0021-9673(85)80044-3Get rights and content

Abstract

High-performance liquid chromatographic determinations of gabexate mesilate (FOY) prostaglandin E1 (PGE1, PGE1-α-cyclodextrin (PGE1,-CD), prednisolone (PD) and butyl flufenamate (BF) incorporated in gel ointment were investigated. The gel ointment is composed of a carboxy vinyl polymer (1.3%, w/w) and a large amount of an aqueous organic solvent. A methanol extraction system offered simultaneous advantages of the removal of the polymer and the recovery of active ingredients from the gel phase. The recoveries of the drugs were 100%. The stabilities of PGE1, PGE1-CD, FOY, PD and BF incorporated in gel ointment, stored at 5, 25 and 40°C for up to 90 days, were investigated.

References (9)

  • G. Di Colo et al.

    J. Pharm. Sci.

    (1980)
  • Y.W. Yip et al.

    J. Pharm. Sci.

    (1983)
  • K. Yamamura et al.

    J. Chromatogr.

    (1984)
  • G. Flynn
There are more references available in the full text version of this article.

Cited by (7)

  • Prednisolone

    1992, Analytical Profiles of Drug Substances and Excipients
  • Chemical stability of prednisone oral suspension and drug substance

    2011, Journal of the Chilean Chemical Society
  • HPLC Methods for Recently Approved Pharmaceuticals

    2005, HPLC Methods for Recently Approved Pharmaceuticals
  • Enhanced Bioavailability of Subcutaneously Injected Insulin by Pretreatment with Ointment Containing Protease Inhibitors

    1991, Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists
View all citing articles on Scopus
View full text